PA
LGND icon

Parallel Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Parallel Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.7K Buy
154
+109
+242% +$25.7K ﹤0.01% 2161
2026
Q1 		$8.98K Sell
45
-28
-38% -$5.54K ﹤0.01% 2797
2025
Q4 		$13.8K Buy
73
+28
+62% +$5.38K ﹤0.01% 2479
2025
Q3 		$7.97K Hold
45
– – ﹤0.01% 2612
2025
Q2 		$5.12K Buy
45
+12
+36% +$1.28K ﹤0.01% 2739
2025
Q1 		$3.47K Hold
33
– – ﹤0.01% 2805
2024
Q4 		$3.54K Buy
33
+31
+1,550% +$3.5K ﹤0.01% 2764
2024
Q3 		$200 Hold
2
– – ﹤0.01% 3302
2024
Q2 		$169 Hold
2
– – ﹤0.01% 3215
2024
Q1 		$146 Hold
2
– – ﹤0.01% 3186
2023
Q4 		$143 Buy
2
+1
+100% +$59 ﹤0.01% 3203
2023
Q3 		$60 Hold
1
– – ﹤0.01% 3302
2023
Q2 		$72 Hold
1
– – ﹤0.01% 3302
2023
Q1 		$74 Hold
1
– – ﹤0.01% 3352
2022
Q4 		$67 Sell
1
-4
-80% -$260 ﹤0.01% 3287
2022
Q3 		$0 Buy
+5
New +$294 ﹤0.01% 3347
2022
Q1 		– Sell
-5
Closed – – 3133
2021
Q4 		$0 Hold
5
– – ﹤0.01% 3197
2021
Q3 		$0 Buy
+5
New +$387 ﹤0.01% 3179
2020
Q1 		– Sell
-10
Closed -$1K – 2532
2019
Q4 		$1K Hold
10
– – ﹤0.01% 2322
2019
Q3 		$1K Buy
+10
New +$628 ﹤0.01% 2289
2017
Q3 		– Sell
-3
Closed – – 2163
2017
Q2 		$0 Buy
+3
New +$210 ﹤0.01% 2156

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's LGND Position: Q2 2026 in Review

Parallel Advisors increased its Ligand Pharmaceuticals (LGND) stake by 242% in Q2 2026, buying an estimated $25.7K and bringing the position to 154 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Parallel Advisors first reported a position in LGND in Q2 2017 and has held it in 21 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Parallel Advisors held 154 shares of Ligand Pharmaceuticals worth $48.7K as of Q2 2026.
  • Parallel Advisors bought 109 Ligand Pharmaceuticals shares in Q2 2026, an estimated $25.7K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2161 holding.
  • Parallel Advisors first reported a position in Ligand Pharmaceuticals in Q2 2017 and has held it in 21 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.